These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12697670)

  • 1. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).
    Schneyer A; Schoen A; Quigg A; Sidis Y
    Endocrinology; 2003 May; 144(5):1671-4. PubMed ID: 12697670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
    Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).
    Arai KY; Tsuchida K; Li C; Watanabe G; Sugino H; Taya K; Nishiyama T
    Protein Expr Purif; 2006 Sep; 49(1):78-82. PubMed ID: 16737827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.
    Bartholin L; Maguer-Satta V; Hayette S; Martel S; Gadoux M; Corbo L; Magaud JP; Rimokh R
    Oncogene; 2002 Mar; 21(14):2227-35. PubMed ID: 11948405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and activin-binding determinants in follistatin and FSTL3.
    Sidis Y; Schneyer AL; Keutmann HT
    Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the activin/follistatin system in hepatocarcinogenesis.
    Grusch M; Drucker C; Peter-Vörösmarty B; Erlach N; Lackner A; Losert A; Macheiner D; Schneider WJ; Hermann M; Groome NP; Parzefall W; Berger W; Grasl-Kraupp B; Schulte-Hermann R
    J Hepatol; 2006 Nov; 45(5):673-80. PubMed ID: 16935389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel factors in regulation of activin signaling.
    Tsuchida K; Nakatani M; Matsuzaki T; Yamakawa N; Liu Z; Bao Y; Arai KY; Murakami T; Takehara Y; Kurisaki A; Sugino H
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):1-8. PubMed ID: 15451561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids.
    Cheng GF; Yuen CW; Ge W
    J Endocrinol; 2007 Dec; 195(3):373-84. PubMed ID: 18000300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental profiles of activin betaA, betaB, and follistatin expression in the zebrafish ovary: evidence for their differential roles during sexual maturation and ovulatory cycle.
    Wang Y; Ge W
    Biol Reprod; 2004 Dec; 71(6):2056-64. PubMed ID: 15329331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pituitary inhibin/activin subunits and follistatin gene expression by GnRH in female rats.
    Popovics P; Rekasi Z; Stewart AJ; Kovacs M
    J Endocrinol; 2011 Jul; 210(1):71-9. PubMed ID: 21490134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the inhibition of activin signalling by follistatin.
    Harrington AE; Morris-Triggs SA; Ruotolo BT; Robinson CV; Ohnuma S; Hyvönen M
    EMBO J; 2006 Mar; 25(5):1035-45. PubMed ID: 16482217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
    Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
    Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-related protein (FSRP): a new member of the follistatin gene family.
    Schneyer A; Tortoriello D; Sidis Y; Keutmann H; Matsuzaki T; Holmes W
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):33-8. PubMed ID: 11451569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.
    Refaat B; Zekri J; Aslam A; Ahmad J; Baghdadi MA; Meliti A; Idris S; Sultan S; Alardati H; Saimeh HA; Alsaegh A; Alhadrami M; Hamid T; Naeem ME; Elsamany SA
    Pathol Oncol Res; 2021; 27():1610032. PubMed ID: 34867090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activins and activin antagonists in the prostate and prostate cancer.
    Gold E; Risbridger G
    Mol Cell Endocrinol; 2012 Aug; 359(1-2):107-12. PubMed ID: 21787836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding.
    Fischer WH; Park M; Donaldson C; Wiater E; Vaughan J; Bilezikjian LM; Vale W
    J Endocrinol; 2003 Jan; 176(1):61-8. PubMed ID: 12525250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities.
    Harrison CA; Chan KL; Robertson DM
    Endocrinology; 2006 Jun; 147(6):2744-53. PubMed ID: 16527838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid.
    Glister C; Groome NP; Knight PG
    J Endocrinol; 2006 Feb; 188(2):215-25. PubMed ID: 16461548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.